Floatz logo

Z/E 4-HYDROXY TAMOXIFEN

Mammographically Dense Breast

M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mammographically Dense Breast cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Z/E 4-HYDROXY TAMOXIFEN is also rated in:

ductal breast carcinoma in situDormant
B
Indicative ·
62 / 100
View asset →
estrogen-receptor positive breast cancerDormant
B
Indicative ·
62 / 100
View asset →
cancerDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →